Methods of using OSK1 peptide analogs
    11.
    发明申请
    Methods of using OSK1 peptide analogs 有权
    使用OSK1肽类似物的方法

    公开(公告)号:US20090318341A1

    公开(公告)日:2009-12-24

    申请号:US11978119

    申请日:2007-10-25

    IPC分类号: A61K38/16 A61P37/00 A61P29/00

    摘要: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.

    摘要翻译: 公开了包含OSK1肽类似物的物质组合物,并且在一些实施方案中为其药学上可接受的盐。 药物组合物包含该组合物和药学上可接受的载体。 还公开了编码本发明组合物的DNA,包含DNA的表达载体和包含表达载体的宿主细胞。 还公开了治疗自身免疫性疾病和预防或减轻多发性硬化症状的复发的方法。

    OSK1 peptide analogs and pharmaceutical compositions
    12.
    发明授权
    OSK1 peptide analogs and pharmaceutical compositions 有权
    OSK1肽类似物和药物组合物

    公开(公告)号:US07803769B2

    公开(公告)日:2010-09-28

    申请号:US11978110

    申请日:2007-10-25

    IPC分类号: A61K38/16 A61K35/56 C07K14/00

    摘要: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.

    摘要翻译: 公开了包含OSK1肽类似物的物质组合物,并且在一些实施方案中为其药学上可接受的盐。 药物组合物包含该组合物和药学上可接受的载体。 还公开了编码本发明组合物的DNA,包含DNA的表达载体和包含表达载体的宿主细胞。 还公开了治疗自身免疫性疾病和预防或减轻多发性硬化症状的复发的方法。

    Methods of using OSK1 peptide analogs
    13.
    发明授权
    Methods of using OSK1 peptide analogs 有权
    使用OSK1肽类似物的方法

    公开(公告)号:US07825093B2

    公开(公告)日:2010-11-02

    申请号:US11978119

    申请日:2007-10-25

    IPC分类号: A61K38/16 A61K35/56 C07K14/00

    摘要: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.

    摘要翻译: 公开了包含OSK1肽类似物的物质组合物,并且在一些实施方案中为其药学上可接受的盐。 药物组合物包含该组合物和药学上可接受的载体。 还公开了编码本发明组合物的DNA,包含DNA的表达载体和包含表达载体的宿主细胞。 还公开了治疗自身免疫性疾病和预防或减轻多发性硬化症状的复发的方法。

    OSK1 peptide analogs and pharmaceutical compositions
    14.
    发明申请
    OSK1 peptide analogs and pharmaceutical compositions 有权
    OSK1肽类似物和药物组合物

    公开(公告)号:US20090281028A1

    公开(公告)日:2009-11-12

    申请号:US11978110

    申请日:2007-10-25

    IPC分类号: A61K38/16 C07K14/00

    摘要: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.

    摘要翻译: 公开了包含OSK1肽类似物的物质组合物,并且在一些实施方案中为其药学上可接受的盐。 药物组合物包含该组合物和药学上可接受的载体。 还公开了编码本发明组合物的DNA,包含DNA的表达载体和包含表达载体的宿主细胞。 还公开了治疗自身免疫性疾病和预防或减轻多发性硬化症状的复发的方法。